Catalyst Wire Dossier Catalyst Wire Dossier

KDS2010

· NeuroBiogen Co., Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KDS2010, covering 2025-07-30 to 2025-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease [Phase 2]

See pricing